Nonalcoholic Steatohepatitis in Chinese Children

Recruiting Observational Study
Non-Alcoholic Fatty Liver Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 – 18
Sex
Any
Study type
Observational
Participants needed
400 (estimated)
Sponsor
Humanity and Health Research Centre · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Nonalcoholic steatohepatitis (NASH) is now recognised as an increasing clinical problem in children. Steatosis without significant liver cell injury or fibrosis is the most common form of nonalcoholic fatty liver disease (NAFLD) in both adults and children. Studies in the adult population have variably suggested that steatosis is a benign nonprogressive condition and NASH is recognised as a potent…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age 1-18 with biopsy-proven NAFLD * Alcohol consumption less than 20g/day and 10g/day for boys and girls respectively Exclusion Criteria: * with viral hepatitis, e.g. HBV, HCV * with a1-anti-trypsin disease * with autoimmune hepatitis * with Wilson disease * with liver impai…
Contacts

George Lau, MD, PhD

852-28613777

gkklau@hnhmgl.com

CONTACT

Yudong Wang, MD, PhD

852-28184300

danny.wang@hnhmgl.com

CONTACT